Arcoma AB Stock Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- | - |
Apr. 25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Jan. 29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 183M 16.96M 0 | Sales 2025 * | 199M 18.44M 0 | Capitalization | 185M 17.17M 0 |
---|---|---|---|---|---|
Net income 2024 * | 14M 1.3M - | Net income 2025 * | 16M 1.48M - | EV / Sales 2024 * | 0.97 x |
Net cash position 2024 * | 7M 649K 0 | Net cash position 2025 * | 19M 1.76M 0 | EV / Sales 2025 * | 0.84 x |
P/E ratio 2024 * |
13.6
x | P/E ratio 2025 * |
11.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.16% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Dahlberg
DFI | Director of Finance/CFO | 40 | 21-12-31 |
Chief Tech/Sci/R&D Officer | 53 | 93-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 21-12-31 | |
Director/Board Member | 53 | 10-02-28 | |
Lars Kvarnhem
CHM | Chairman | 52 | 16-12-31 |
1st Jan change | Capi. | |
---|---|---|
-0.97% | 15.26B | |
-36.20% | 3.01B | |
-12.03% | 2.44B | |
-12.41% | 1.46B | |
-.--% | 1.12B | |
+65.31% | 591M | |
+14.60% | 247M | |
-2.35% | 231M | |
+7.96% | 194M |